This improvement is highly significant given the physical limitations and reduced mobility often caused by lytic metastases in the spine, pelvis, and femurs and their consequence on overall quality of life.
← all excerpts
Combining a 9-month tailored physical exercise program with osimertinib and denosumab in a patient affected by advanced NSCLC with multiple osteolytic bone lesions: A case report.
1
—
—